Intellectual property and nanopharmaceuticals

• Type: Chapter or Part of a Book
• Date: 2012

Authors

Puthli, SP (Author) Other; Puthli, MS (Author) Other; Macedo, AS (Author) Other; Souto, EB (Author) Other

Book

Title: Patenting Nanomedicines: Legal Aspects, Intellectual Property and Grant Opportunities

Pages: 3-24

ISBN: 9783642292651; 364229264X; 9783642292644

Publisher: Springer Berlin Heidelberg

Indexing

Scopus - 1 Citation

Other information

Authenticus ID: P-00K-1TT

DOI: 10.1007/978-3-642-29265-1_1

Abstract (EN): Nanopharmaceuticals are a promising pathway to overcome traditional therapeutic limitations, since they are formulated to have high affinity to a specific target. These formulations are an improvement of old formulations resulting in better patient compliance. To acquire commercialization rights over a formulation it is necessary to patent the invention. Patenting an invention is crucial for nanomedicine evolution. The significance of intellectual property in this field has led to many startup companies to patent their technology. Licensing agreements have been one of the important options for many entrepreneurs with suitable benefit to both the parties. Due to initiatives taken by government (like implementation of the Bayh Dole Act, in the USA), the industry-academia collaborative research activities have increased to a large extent. © 2012 Springer-Verlag Berlin Heidelberg. All rights are reserved.

Language: English

Type (Professor's evaluation): Scientific